Treatment of Recurrent Epidermolysis Bullosa Acquisita With Tofacitinib
2023; American Medical Association; Volume: 159; Issue: 3 Linguagem: Inglês
10.1001/jamadermatol.2022.6250
ISSN2168-6084
Autores Tópico(s)Coagulation, Bradykinin, Polyphosphates, and Angioedema
ResumoThis case report describes a patient with recurrent epidermolysis bullosa acquisita who was treated with tofacitinib.
Referência(s)